PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical Trial
(NASDAQ: PRFX) Delayed: 1.60 -0.05 (3.03%)
Previous Close $1.65    52 Week High $ 
Open $1.61    52 Week Low $ 
Day High $1.84    P/E N/A 
Day Low $1.57    EPS $ 
Volume 576,472